Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ROSG

(ROSG) (ROSG) Stock Price, News & Analysis

(ROSG) logo

About (ROSG) Stock (NASDAQ:ROSG)

Advanced Chart

Key Stats

Today's Range
$0.42
$0.44
50-Day Range
$0.43
$0.43
52-Week Range
$0.23
$2.75
Volume
169,599 shs
Average Volume
81,512 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.

Receive ROSG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ROSG) and its competitors with MarketBeat's FREE daily newsletter.

ROSG Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
Rosetta Genomics Ltd ROSGQ
See More Headlines

ROSG Stock Analysis - Frequently Asked Questions

(ROSG) (NASDAQ:ROSG) announced its quarterly earnings results on Thursday, May, 19th. The medical research company reported ($0.18) EPS for the quarter, missing analysts' consensus estimates of ($0.16) by $0.02. The medical research company earned $2.60 million during the quarter, compared to the consensus estimate of $3.36 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ROSG) investors own include Agenus (AGEN), Bausch Health Companies (BHC), Endocyte (ECYT), Intercept Pharmaceuticals (ICPT), BIOLASE (BIOL), EyePoint Pharmaceuticals (EYPT) and (SCMP) (SCMP).

Company Calendar

Last Earnings
5/19/2016
Today
5/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ROSG
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:ROSG) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners